This website is intended for healthcare professionals only

Trending Topic

Glucose meter device with test strips and lancets on a blue textured background
14 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Type 2 diabetes (T2D) is a progressive metabolic condition associated with obesity, cardiovascular disease and substantial morbidity and mortality.1 Despite the availability of multiple glucose-lowering therapies, a significant proportion of individuals with T2D fail to achieve recommended glycemic targets, particularly those with long disease duration, obesity and insulin resistance.2,3 In parallel, excess adiposity remains a major driver of […]

Andrea R Genazzani, WCO IOF-ESCEO 2022: Hormone Replacement Therapy for Bone Loss Prevention Post Menopause (Part 2)

7 mins
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Apr 5th 2022

It was a pleasure to talk with Dr. Andrea R Genazzani (International Society of Gynecological Endocrinology and European Society of Gynecology) to find out when, in whom and for how long hormone replacement therapy should be administered for bone loss prevention post-menopause.

Hormone Replacement Therapy in post-menopause for bone loss prevention: when, how and for how long‘ was presented at WCO IOF-ESCEO 2022, 24-26 March, 2022

Questions

  1. When and in whom should HRT be considered for bone loss prevention? (1:16)
  2. How can HRT be administered? (3:45)
  3. For how long should HRT be administered? (5:59)

Disclosures: Andrea R Genazzani has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.

Filmed in coverage of the WCO IOF-ESCEO annual meeting 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup